Symbols

SIBN

SI-BONE·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 2

Consensus Rating "Strong Buy"

Price Hits 52-week Low

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SIBN

Si-Bone, Inc.

A developer of proprietary minimally invasive surgical implant system to treat sacroiliac joint dysfunction

Industry

Healthcare Equipment and Supplies

Established Date

03/18/2008

Listing Date

10/17/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

376

Fiscal Year Ends

12-31

Website

www.si-bone.com

Security Type

Common stock

Office address

471 El Camino Real, Suite 101, Santa Clara, California 95050

Business

Introduction

SI-BONE, Inc., was incorporated in Delaware on March 18, 2008. The company is a leader in the development of innovative procedural solutions for damaged bones, building on expertise in biomechanical design and anatomy-specific innovations. With its experience in additive manufacturing or 3 D printing developed in sacroiliac fusion, the company has established a technology platform that can now be expanded to meet critical unmet needs in thoracolumbar fixation and fusion and pelvic trauma. The company's products include a range of patented titanium implants and their implanted devices, as well as implantable bone products. Since the launch of the first generation iFuse in 2009, the company has launched several implant product lines, including iFuse 3 D in 2017, iFuse TORQ in 2021, iFuse Bedrock Granite in 2022, and iFuse INTRA and iFuse TORQ TNT in 2024.

Company Financials

EPS

SIBN has released its 2025 Q4 earnings. EPS was reported at -0.04, versus the expected -0.12, beating expectations. The chart below visualizes how SIBN has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SIBN has released its 2025 Q4 earnings report, with revenue of 56.35M, reflecting a YoY change of 14.99%, and net profit of -1.64M, showing a YoY change of 63.43%. The Sankey diagram below clearly presents SIBN's revenue sources and cost distribution.